We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alltracel PH. | LSE:AP. | London | Ordinary Share | IE0030515666 | ORD EUR0.0125 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 13.82 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:6893M
Alltracel Pharmaceuticals Plc
28 January 2008
Alltracel Pharmaceuticals plc (the 'Company')
Holdings in Company
The Company received notification on 28 January, 2008 from Appian Wealth
Management that, following an acquisition of 50,000 shares on 23 January 2008,
Appian Wealth Management is now interested in 10,130,296 ordinary shares of the
Company, representing approximately 7.1 per cent. of the Company's issued share
capital.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBPMATMMMTBBP
1 Year Alltracel Pharmaceuticals Chart |
1 Month Alltracel Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
